[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":42837000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":523800000.0,"AmortizationOfLeaseIncentives_1_Q1_USD":53000.0,"AdministrativeFeesExpense_1_Q1_USD":75000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":880000.0,"AmortizationOfFinancingCosts_1_Q1_USD":231000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":16618000.0,"OtherLiabilitiesCurrent_0_Q1_USD":14460000.0,"ShortTermInvestments_0_Q1_USD":52334000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":472774000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-81924000.0,"OtherAssetsCurrent_0_Q1_USD":4804000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":4107000.0,"TreasuryStockValue_0_Q1_USD":234000.0,"TreasuryStockShares_0_Q1_shares":41309.0,"IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_1_Q1_USD":904000.0,"LongTermDebtCurrent_0_Q1_USD":30127000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":-38000.0,"StockOptionPlanExpense_1_Q1_USD":568000.0,"ProceedsFromWarrantExercises_1_Q1_USD":128000.0,"NonoperatingIncomeExpense_1_Q1_USD":-1426000.0,"IncreaseDecreaseInOtherCurrentLiabilities_1_Q1_USD":-3717000.0,"DeferredRevenueNoncurrent_0_Q1_USD":571000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_1_Q1_USD":-308000.0,"InvestmentIncomeAmortizationOfPremium_1_Q1_USD":127000.0,"RestrictedStockExpense_1_Q1_USD":16050000.0,"RestrictedCashNoncurrent_0_Q1_USD":1260000.0,"RestrictedCash_0_Q1_USD":1260000.0,"ReceivablesNetCurrent_0_Q1_USD":771000.0,"OtherSellingGeneralAndAdministrativeExpense_1_Q1_USD":17655000.0,"OtherResearchAndDevelopmentExpense_1_Q1_USD":55583000.0,"OtherLongTermDebt_0_Q1_USD":30000000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":9141000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":10349000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1533000.0,"OperatingLeaseLiability_0_Q1_USD":11882000.0,"OperatingLeaseCost_1_Q1_USD":532000.0,"NotesPayableFairValueDisclosure_0_Q1_USD":880000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":7158000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":2035000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2040000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1924000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":1653000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":9884000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":17536000.0,"LeaseCost_1_Q1_USD":532000.0,"LongTermDebt_0_Q1_USD":30127000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":479000.0,"Goodwill_0_Q1_USD":799000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":445285000.0,"ProfitLoss_1_Q1_USD":-90628000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":67000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-81355000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-514000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-55000.0,"LiabilitiesCurrent_0_Q1_USD":92494000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":548699000.0,"Liabilities_0_Q1_USD":103414000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":771000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":488000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.69,"CostOfRevenue_1_Q1_USD":139000.0,"CommonStockValue_0_Q1_USD":142000.0,"CommonStockSharesOutstanding_0_Q1_shares":141479387.0,"CommonStockSharesIssued_0_Q1_shares":141520696.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":471514000.0,"AssetsCurrent_0_Q1_USD":535013000.0,"Assets_0_Q1_USD":548699000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":12129734.0,"AdditionalPaidInCapital_0_Q1_USD":1516602000.0,"Depreciation_1_Q1_USD":59000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1071225000.0,"Revenues_1_Q1_USD":793000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":131898626.0,"DeferredCompensationLiabilityCurrent_0_Q1_USD":3537000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q1_shares":147058.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":4.08,"OtherIncome_1_Q1_USD":472000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":128000.0,"ShareBasedCompensation_1_Q1_USD":16618000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":26762000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":63094000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"OperatingIncomeLoss_1_Q1_USD":-89202000.0,"OperatingExpenses_1_Q1_USD":89995000.0,"InterestPaidNet_1_Q1_USD":769000.0,"InterestExpense_1_Q1_USD":1898000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":-507000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommitmentsAndContingencies_0_Q1_USD":null,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q1_USD":880000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":848000.0,"Ticker":"TGTX","CIK":"1001316","name":"TG THERAPEUTICS, INC.","OfficialName":"TG Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1036853809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]